Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 in acute noninfectious uveitis
NCT01791192Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Nov 2013
- Primary completion
- Oct 2014
01
Overview
A Phase 2 trial of fingolimod in non-infectious intermediate uveitis, non-infectious posterior uveitis (NIPU), non-infectious panuveitis (NIU), sponsored by Novartis. Planned start Nov 2013; status: withdrawn.
02
Drugs
fingolimod
03
Conditions
non-infectious intermediate uveitisnon-infectious posterior uveitis (NIPU)non-infectious panuveitis (NIU)
Beyond the preview
Go deeper on NCT01791192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791192.